awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33577870-F3597171-99D0-4A73-8F2A-DE964A995B55
Q33577870-F3597171-99D0-4A73-8F2A-DE964A995B55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33577870-F3597171-99D0-4A73-8F2A-DE964A995B55
Efficacy and tolerability of different starting doses of sorafenib in patients with differentiated thyroid cancer.
P2860
Q33577870-F3597171-99D0-4A73-8F2A-DE964A995B55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33577870-F3597171-99D0-4A73-8F2A-DE964A995B55
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
93a7f1d529ed7877ed9c8f690a6fa794e42d0188
P2860
Phase II trial of sorafenib in advanced thyroid cancer.